Tuesday July 16, 2019 03:33

CARDIO Press Releases

Oral semaglutide demonstrated cardiovascular safety in people with type 2 diabetes and established Heathcare—12 Jun 19

Novo Nordisk today announced that the PIONEER 6 trial achieved its primary endpoint by demonstrating non-inferiority of major adverse cardiovascular events (MACE) with oral semaglutide compared with placebo, both in addition to standard of care. The

World Congress of Cardiology Cardiovascular Health 2018 Opens in Dubai Heathcare—06 Dec 18

- Professor David Wood, President of the World Heart Federation, welcomes more than 5000 cardiologists, doctors, nurses, and health and policy experts from around the world to Dubai for WCC 2018 at a time when the opportunities for a sustainable impact

American College of Cardiology recommends empagliflozin as preferred SGLT2 inhibitor for adults Heathcare—27 Nov 18

A new Expert Consensus Decision Pathway issued by the American College of Cardiology (ACC) recommends empagliflozin as the preferred SGLT2 inhibitor for its proven benefit in reducing the risk of cardiovascular death in adults with type 2 diabetes and

รพ.ลานนา จัดการอบรม การช่วยชีวิตขั้นสูง ACLS สุขภาพ—29 Oct 18

โรงพยาบาลลานนา ได้จัดการฝึกอบรมหลักสูตรการฝึกยกระดับฝีมือแรงงาน สาขาการช่วยชีวิตขั้นสูง (Advance Cardiovascular Life Support) โดยมี นพ.สุรชัย สาธิตสมิตพงษ์ แพทย์เวชศาสตร์ฉุกเฉิน และ นพ.อภินันท์ ตันติวุฒิ อายุรแพทย์ โรงพยาบาลลานนา

Herbalife Nutrition Presents Products with Thai Food Good Heart emblem at 23rd ASEAN Federation Business—18 Oct 18

Herbalife Nutrition, a premier global nutrition company whose purpose is to make the world healthier and happier, recently presented its Formula 1 Nutritional Protein Drink Mix products which were certified and allowed to use "Thai Food Good Heart"

เฮอร์บาไลฟ์ นิวทริชั่น ร่วมจัดแสดงผลิตภัณฑ์ตราสัญลักษณ์ อาหารรักษ์หัวใจในงาน ASEAN Federation สุขภาพ—18 Oct 18

เฮอร์บาไลฟ์ นิวทริชั่น ร่วมจัดแสดงผลิตภัณฑ์ตราสัญลักษณ์ "อาหารรักษ์หัวใจ"ในงาน ASEAN Federation Congress of Cardiology 2018 ครั้งที่ 23 เมื่อเร็ว ๆ นี้ เฮอร์บาไลฟ์ นิวทริชั่น

Latest state-of-the-art health check-up technology comes to Thailand General—16 Oct 18

Verita Health MahaNakhon (VMH) is introducing "Verita Wisdom", a new 360° state-of-the-art Cardiometabolic Health Check to Thailand to analyze customers' cardiovascular risk situation within 30 minutes. "We are delighted to be able to exclusively

International Diabetes Federation (IDF) Global Survey Reveals 2 in 3 People With Type 2 Diabetes Heathcare—28 Sep 18

- Cardiovascular disease (CVD) is the leading cause of disability and death in people with type 2 diabetes[1] - Despite the high incidence, 1 in 4 people with type 2 diabetes have never discussed, or cannot recall discussing, CVD risk factors with a

World Heart Day: Nearly One in Five Deaths From Cardiovascular Disease are Caused by Air Pollution, Heathcare—27 Sep 18

- On World Heart Day (WHD), 29 September 2018, World Heart Federation (WHF) is raising awareness of the link between poor air quality and cardiovascular disease (CVD) - Outdoor and household air pollution are an increasingly important risk factor for

Venus Medtech Launches Global Advisory Board to Target for International Heathcare—25 Sep 18

Venus Medtech (Hangzhou) Inc., a Chinese medical device company specializing in transcatheter valve replacement therapy, has retained four world-renowned experts specialized in interventional cardiovascular to form a Global Advisory Board. The Board

Ozempic(R) Consistently Reduced the Risk of Major Cardiovascular Events Across Type 2 Diabetes Heathcare—27 Aug 18

Ozempic(R) (semaglutide) consistently reduced the risk of the composite outcome of time to first occurrence of non-fatal heart attack, non-fatal stroke or cardiovascular death (collectively termed major adverse cardiovascular events, MACE) in people with

Bayer hosted the Asia Pacific Thrombosis Management: Connecting Patient Care 2018 event in General—15 Aug 18

Bayer hosted the Asia Pacific Thrombosis Management: Connecting Patient Care 2018 event in Bangkok, Thailand from 28-29 July 2018. More than 200 physicians and renowned experts in the field of cardiovascular medicine from Asia-Pacific, Europe and North

Cardiologist Reccomends Top 3 Steps to Help Prevent Heart Disease in Heathcare—15 Mar 18

Bangkok, In Thailand, an average of 150 people per day, or six people per hour die from heart disease according to the Ministry of Public Health who reported that from 2012 to 2016, the average number of deaths caused by heart disease was approximately

World Heart Federation: Tobacco is Responsible For More Than One in Ten Deaths Caused by Heathcare—30 May 18

- The theme of WHO World No Tobacco Day 2018 on 31 May is: "Tobacco breaks hearts, choose health and not tobacco" - Smoking is associated with around 7 million global deaths per year and is an independent, major risk factor for myocardial infarction,

Burn those calories with Zumba at LifeStyles on 26, Centara Grand at General—29 Dec 17

Whoever said working out (and working up a sweat) can't be fun clearly has never tried one of our Zumba classes here at LifeStyles on 26, Centara Grand & Bangkok Convention Centre at CentralWorld! With an emphasis on cardio, this total body workout

ทีมแพทย์บราซิลประสบความสำเร็จในการใส่ลิ้นหัวใจพัลโมนารี VenusP-Valve สุขภาพ—25 Dec 17

ทีมแพทย์บราซิล ซึ่งนำโดยศาสตราจารย์การ์ลอส เปดรา จากสถาบัน Dante Pazzanese Institute of Cardiovascular Technology ในเมืองเซาเปาโล ประสบความสำเร็จในการใส่ลิ้นหัวใจพัลโมนารี VenusP-Valve ผ่านสายสวนในระดับคลินิก 4 ครั้ง เมื่อวันที่ 19 ธันวาคม 2560

First Successful Clinical Implantation of Transcatheter Pulmonary Valve VenusP-Valve was Heathcare—25 Dec 17

On December 19, 2017, local time, 4 clinical implantations of transcatheter pulmonary valve VenusP-Valve were successfully completed in Brazil by Professor Carlos Pedra from Dante Pazzanese Institute of Cardiovascular Technology in Sao Paulo,

The Best Cardio to Burn Calories Heathcare—20 Dec 17

Herbalife Nutrition's Senior Director of Worldwide Sports Performance and Fitness Samantha Clayton was in Thailand recently, as the speaker for the company's 8th Asia Pacific Wellness Tour. On this special occasion, the Football Association of Thailand

Interim Results of First-Ever Global Survey Show People with Type 2 Diabetes Underestimate their Heathcare—06 Dec 17

- Globally, cardiovascular disease (CVD) is the most common cause of death in people with type 2 diabetes[1] - 1 in 3 respondents considered themselves to be at low risk of CVD[2] - 1 in 6 respondents had never discussed type 2 diabetes and

#บี้ สุกฤษฎิ์ แทคทีม #ครูหนุ่ม 911 ชวนแดนซ์ #Zumba Cardio ใน #FM ONE Holistic Health Share # 2 : บันเทิง—10 Nov 17

""FM ONE Holistic Health Share # 2 : Zumba Party อย่าปล่อยให้หัวใจหยุดเต้น"" ชวนคุณผู้ฟังใจบุญมาออกสเต็ปโชว์ลีลาZumba Cardio ไปพร้อมๆ บทเพลงจาก ""บี้-สุกฤษฎิ์ วิเศษแก้ว"" งานนี้ได้รับเกียรติจากครูสอนเต้นซุมบ้าแถวหน้าของเมืองไทย ""ครูหนุ่ม911 By JT The

IDF and Novo Nordisk Launch First-ever Global Survey on Cardiovascular Disease Awareness among Heathcare—29 Sep 17

- Taking Diabetes to Heart is a global online survey for people with type 2 diabetes to gain important insights about their awareness of cardiovascular disease (CVD) - Globally, CVD is the most common cause of death in people with type 2 diabetes[1] -

Xultophy(R) Reduces Cardiovascular Risk Factors in People with Type 2 Heathcare—14 Sep 17

In people with type 2 diabetes, Xultophy(R) (insulin degludec/liraglutide) significantly reduced a number of risk factors associated with an increased risk of cardiovascular disease (CVD), compared to basal insulin.[1] According to a new post-hoc

Victoza(R) Reduces the Risk of Major Cardiovascular Events in People with Type 2 Diabetes With or Heathcare—29 Aug 17

A new analysis of the landmark LEADER trial shows that Victoza(R) (liraglutide) reduced the risk of major cardiovascular (CV) events in people with type 2 diabetes at high CV risk, irrespective of their history of having a heart attack and/or stroke or

เชิญผู้ที่สนใจเข้าร่วมประชุมวิชาการ CMCC Nurse Forum ตามรอยจังหวะหัวใจ สุขภาพ—16 Aug 17

โรงพยาบาลกรุงเทพเชียงใหม่ ร่วมกับ คณะแพทย์ศาสตร์ มหาวิทยาลัยเชียงใหม่ ขอเรียนเชิญผู้ที่สนใจทุกท่านเข้าร่วมประชุมวิชาการ "ตามรอยจังหวะหัวใจ" (Preliminary Session in Chiang Mai Cardiology Conference : CMCC) โดยจะจัดขึ้นในวันที่ 7 กันยายน 2560 เวลา 08.00 -

New LEADER Analysis Shows Victoza(R) Reduces Cardiovascular Risk in People With Type 2 Diabetes Heathcare—13 Jun 17

Findings from a post hoc analysis of the LEADER cardiovascular (CV) outcomes trial showed that treatment with Victoza(R) (liraglutide) resulted in similar reductions in the risk of major cardiovascular events in people with type 2 diabetes at high CV

Tresiba(R) Demonstrated No Increased Risk Of Major Cardiovascular Events and Significant Reduction Heathcare—13 Jun 17

Novo Nordisk today announced the primary results from DEVOTE - the first randomised, double-blind, treat-to-target, event-driven trial comparing two basal insulins, Tresiba(R) (insulin degludec injection 100 U/mL) and insulin glargine U100, in adults

Getinge Announces Results of Study of Contemporary Practice Showing Larger Volume Intra-Aortic General—04 May 17

Data Shows Counterpulsation Therapy with 50cc Balloon Represents Safe, Clinically Effective, Cost-Conservative Strategy in Managing Critically Ill Cardiac Patients Getinge, a leading global provider of products and systems that contribute to quality

Venus Medtech#s TAVR Device Is Approved By CFDA, Creating A New Era Of Interventional Cardiology In Heathcare—02 May 17

Venus Medtech (Hangzhou) Inc., announced on April 25th that its transcatheter aortic valve system - Venus A-valve - has been approved by China Food and Drug Administration ("CFDA") (registration no.: 20173460680) for sale in China. This marks the

KTC organizes a special activity - Old but not be Forgotten to preserve Thai Stcoks—07 Apr 17

Recently, "KTC PR Press Club" operators of "KTC" or Krungthai Card Public Company Limited organized a special cultural trip titled "Old but not be Forgotten" by arranging herbal and cardio tonic medical learnings at "Bamroong Chat Satsanaa Yathai"